Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 600 35 987.5 |
96 | EP file number | EAKZ | 00 92 8616.2 |
86 | WO file number | WAKZ | PCT/US00/11652 |
97 | EP publication number | EPN | 1187628 |
87 | WO publication number | WPN | 2000066142 |
54 | Designation/title | TI | METABOLISCHE INTERVENTION MIT GLP-1 ODER SEINEN BIOLOGISCH AKTIVEN ANALOGEN ZUR VERBESSERUNG DER FUNKTION DES ISCHÄMISCHEN UND WIEDERDURCHBLUTETEN GEHIRNS |
51 | IPC main class | ICM (ICMV) | A61K 38/26 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 9/10 (2006.01) |
22 | DE application date | DAT | May 1, 2000 |
96 | EP application date | EAT | May 1, 2000 |
86 | WO application date | WAT | May 1, 2000 |
43 | Date of first publication | OT | Nov 9, 2000 |
| Date of publication of grant | PET | Aug 15, 2007 |
71/73 | Applicant/owner | INH | Amylin Pharmaceuticals, LLC, San Diego, Calif., US; AstraZeneca Pharmaceuticals LP, 19803 Wilmington, Del., US |
72 | Inventor | IN | COOLIDGE, Thomas, R., Lincoln, NE 68524, US; EHLERS, Mario, R., Lincoln, NE 68524, US |
74 | Representative | VTR | Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, 22607 Hamburg, DE |
10 | Published DE documents | DEPN | Original document:
DE000060035987T2 Searchable text:
DE000060035987T2 |
| Address for service | | Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, 22607 Hamburg, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 303016 Apr 30, 1999
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| Published EP/WO documents | EPWOPN | Original document:
EP000001187628 Searchable text:
EP000001187628 Original document:
EP000001187628B1 Searchable text:
EP000001187628B1 Original document:
WO002000066142 Searchable text:
WO002000066142 |
43 | Date of first publication | EVT | Nov 9, 2000 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 5, 2022 (Show all update days)(Hide all update days)- Jan 5, 2022; Oct 25, 2018; Mar 1, 2017; Jan 17, 2017; Jun 9, 2016; Oct 23, 2015; May 13, 2015; Jun 12, 2014; May 14, 2014; Sep 24, 2013; Aug 1, 2013; Jun 11, 2013; Jun 4, 2013; May 24, 2013; Jan 23, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 11)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 10, 2013 |
| Issue number | HN | 31 |
| Year | PJ | 2013 |
| Publication date | VT | Aug 1, 2013 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | Amylin Pharmaceuticals, LLC, San Diego, Calif., US; AstraZeneca Pharmaceuticals LP, 19803 Wilmington, Del., US |
71/73 | Previous applicant/owner | INHF | Amylin Pharmaceuticals, LLC, San Diego, Calif., US |